{"id":8247,"date":"2024-09-02T14:29:33","date_gmt":"2024-09-02T14:29:33","guid":{"rendered":"https:\/\/bofillmir.cl\/?p=8247"},"modified":"2026-02-16T22:30:24","modified_gmt":"2026-02-16T22:30:24","slug":"alerta-legal-3","status":"publish","type":"post","link":"https:\/\/bofillmir.cl\/eng\/alerta-legal-3\/","title":{"rendered":"Legal Alert"},"content":{"rendered":"<p>El Ministerio de Salud actualiza el listado de f\u00e1rmacos oncol\u00f3gicos de alto costo no GES, ampliando el cat\u00e1logo de medicamentos con mecanismos de acceso y financiamiento estatal.<\/p>\n\n\n\n<p>En el contexto de los mecanismos legales de financiamiento de medicamentos de alto costo, y en especial f\u00e1rmacos oncol\u00f3gicos no GES (es decir, no contempladas en la Ley 19.966 que establece un r\u00e9gimen de garant\u00edas en salud, o \u201cLey GES\u201d), el Ministerio de Salud defini\u00f3 una nueva lista de medicamentos de dicha categor\u00eda, con el fin de actualizar el listado vigente y asegurar el acceso de pacientes a dichos productos.<\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2024\/09\/Alerta-Legal-Resolucion-Exenta-N1099-LS.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of Alerta Legal Resoluci\u00f3n Exenta N1099 LS.\"><\/object><a id=\"wp-block-file--media-6b71bfd3-7269-432f-bc41-9e3bbf33ee0e\" href=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2024\/09\/Alerta-Legal-Resolucion-Exenta-N1099-LS.pdf\">Alerta Legal Resoluci\u00f3n Exenta N1099 LS<\/a><a href=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2024\/09\/Alerta-Legal-Resolucion-Exenta-N1099-LS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-6b71bfd3-7269-432f-bc41-9e3bbf33ee0e\">Download<\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>El Ministerio de Salud actualiza el listado de f\u00e1rmacos oncol\u00f3gicos de alto costo no GES, ampliando el cat\u00e1logo de medicamentos con mecanismos de acceso y financiamiento estatal. En el contexto de los mecanismos legales de financiamiento de medicamentos de alto costo, y en especial f\u00e1rmacos oncol\u00f3gicos no GES (es decir, no contempladas en la Ley [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5869,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-8247","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alerta-legal"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/8247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/comments?post=8247"}],"version-history":[{"count":1,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/8247\/revisions"}],"predecessor-version":[{"id":8249,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/8247\/revisions\/8249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/media\/5869"}],"wp:attachment":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/media?parent=8247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/categories?post=8247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/tags?post=8247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}